Conversely, in HPV-positive tumours activating alterations frequently occur in PIK3CA, FGFR3 and E2F1, with HPV-oncoproteins E6 and E7 causing inactivation of wild-type TP53 and RB1 functions in cell cycle control [43,44]. This evidence concerns the gene TP53 and neoplasm.